Lenvatinib Efficacy in Metastatic Neuroendocrine Tumors
Clinical trial NCT02678780 · COMPLETED
Trial details
- NCT number
- NCT02678780
- Sponsor
- Grupo Espanol de Tumores Neuroendocrinos
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-10-01
- Primary completion
- 2017-12-01
- Enrollment
- 123
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.